Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Apurva A. Motivala"'
Autor:
Abhiram Prasad, J. Dawn Abbott, Debabrata Mukherjee, David Dai, Valay Parikh, Matthew T. Roe, Apurva A. Motivala
Publikováno v:
JACC: Cardiovascular Interventions. 9:1639-1648
Objectives This study sought to examine predictors, trends, and outcomes associated with β-blocker prescriptions at discharge in patients with stable angina without prior history of myocardial infarction (MI) or systolic heart failure (HF) undergoin
Autor:
Apurva A, Motivala, Valay, Parikh, Matthew, Roe, David, Dai, J Dawn, Abbott, Abhiram, Prasad, Debabrata, Mukherjee
Publikováno v:
JACC. Cardiovascular interventions. 9(23)
Autor:
Apurva A, Motivala, Valay, Parikh, Matthew, Roe, David, Dai, J Dawn, Abbott, Abhiram, Prasad, Debabrata, Mukherjee
Publikováno v:
JACC. Cardiovascular interventions. 9(16)
This study sought to examine predictors, trends, and outcomes associated with β-blocker prescriptions at discharge in patients with stable angina without prior history of myocardial infarction (MI) or systolic heart failure (HF) undergoing elective
Autor:
David Dai, Apurva A. Motivala, Deepak L. Bhatt, Vankeepuram S. Srinivas, Eric D. Peterson, Christopher P. Cannon, Adrian F. Hernandez, Gregg C. Fonarow
Publikováno v:
Journal of the American College of Cardiology. 58:1760-1765
Objectives The goals of this analysis were to determine: 1) whether guideline-based care during hospitalization for a myocardial infarction (MI) varied as a function of patients' baseline risk; and 2) whether temporal improvements in guideline adhere
Autor:
Apurva A. Motivala, Kim A. Eagle, Eva Kline-Rogers, Melvyn Rubenfire, Daniel G. Montgomery, Hitinder S. Gurm, Fadi Saab, Debabrata Mukherjee
Publikováno v:
Scopus-Elsevier
Patients with acute coronary syndromes (ACS) have a poor short- and long-term prognosis. We sought to examine the presence of established coronary risk factors in contemporary patients presenting with an ACS for the first time and no known coronary a
Autor:
Patricia A. Rose, Apurva A. Motivala, Robert D. Brook, Otto Muzik, Yolanda R. Smith, H. Myra Kim, Catherine Bartnik, Claire S. Duvernoy
Publikováno v:
Journal of Nuclear Cardiology. 15:510-517
Background. This study was designed to determine whether overweight or obese status is independently associated with myocardial flow reserve (MFR), an established predictor of cardiovascular mortality, in a group of postmenopausal women with no previ
Autor:
Fadi Saab, Jin Li, Kim A. Eagle, Apurva A. Motivala, Daniel G. Montgomery, Jignesh Bhavsar, John Del Valle, Vikas I. Parekh, James B. Froehlich, Eva Kline-Rogers
Publikováno v:
The American Journal of Medicine. 120:968-974
In July 2003, the Accreditation Council for Graduate Medical Education instituted residency duty-hours requirements in response to growing concerns regarding clinician fatigue and the incidence of medical errors. These changes, which limited maximum
Autor:
Umesh U. Tamhane, Apurva A. Motivala, Eva Kline Rogers, Kim A. Eagle, Mauro Moscucci, Jin Li, Hitinder S. Gurm, James B. Froehlich, Fadi Saab
Publikováno v:
The American Journal of Cardiology. 100:1359-1363
Antithrombotic and antiplatelet agents are essential for the management of patients with acute coronary syndromes (ACSs). These pharmacologic agents have the potential for increased risk of bleeding. It is not clear if the increased uptake of these t
Autor:
Bertram Pitt, Apurva A. Motivala
Publikováno v:
Drugs. 67:647-655
The use of combined estrogen/progesterone has been shown to result in an increased cardiovascular risk in randomised double-blinded trials. However, these studies used oral progestogen (progestin) preparations, which lack anti-mineralocorticoid activ
Autor:
Abhiram Prasad, Debabrata Mukherjee, Matthew T. Roe, Apurva A. Motivala, J. Dawn Abbott, David Dai, Valay Parikh
Publikováno v:
JACC: Cardiovascular Interventions. 9:2459-2460
We want to thank Dr. Maekawa for their interest in our recent study on β-blocker use in patients with stable angina undergoing elective percutaneous coronary intervention [(1)][1]. Our paper demonstrated that use of β-blockers at the time of discha